글로벌 Psittacosis 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 Psittacosis 치료 시장

글로벌 앵무새증 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 위에 언급된 연구 예측 기간 동안 5.80%의 건강한 CAGR로 성장하고 있다고 분석합니다.

앵무새열이라고도 불리는 앵무새열병은 클라미디아 앵무새로 인해 발생하는 희귀한 감염성 질환입니다. 질병통제예방센터(CDC)의 데이터에 따르면 미국에서는 2010년 이후로 사람에게서 앵무새 열병 이 10건 미만으로 관찰되었습니다 . 그러나 이러한 사례는 증상이 다른 질병과 여러 가지 유사성을 보이기 때문에 진단되지 않습니다. 앵무새만이 질병을 일으키는 것이 아니라 칠면조, 앵무새, 닭, 코카티엘, 오리와 같은 다른 감염된 야생 및 애완용 새도 사람에게 감염을 전파할 수 있습니다. 감염의 심각성으로 인해 조류 독감이 발생할 수도 있습니다. 감염된 사람에게 보고된 증상은 폐렴, 독감, 발열, 오한, 근육, 관절통, 다발성 장기 부전 설사 및 쇠약입니다. 앵무새열병은 혈액 및 가래 검사로 진단합니다. 이 두 가지 검사는 환자에게 감염을 일으킬 수 있는 박테리아를 판별할 수 있습니다. 흉부 X선 검사는 폐렴 징후를 보일 수 있습니다. 항체가 검사는 의료 전문가가 Psittacosis를 유발하는 박테리아에 대한 항체를 확인하기 위해 수행합니다. 항체 양의 변화는 환자가 박테리아에 감염되었는지 여부를 판단할 수 있습니다 . 개인이 반응하는 데 걸리는 시간은 24시간에서 72시간 이내입니다.

Psittacosis are treated with tetracycline and doxycycline. Tetracycline and doxycycline are the two antibiotics which are effective against the disease. Children aged below 10years, are cured with azithromycin. The recovery criteria have proven to be successful. The recovery progress however has been slow in the elderly population. The number of deaths caused due to parrot fever is rare. The disease can be prevented by cleaning the bird cages every day and taking optimum care of the pet birds to avoid them getting infected.

The rising cases of parrot fever, rise in geriatric population, lack of sanitation, increased number of government initiatives for health protection of birds, investment by R&D in pharmaceutical companies, rise in measures to avoid Psittacosis infection and availability of antibiotics for Psittacosis Treatment are predicted to drive the market growth. However, the lack of health remuneration policies, rise in cost, side effects associated with the use of antibiotics and the risk of other diseases linked with Psittacosis infection are expected to hinder the market growth. The rise of emerging markets in developing countries, rise of untapped opportunities, upcoming veterinary clinics, strategic initiatives by the market players are the opportunities which are projected to bolster the market growth. The lack of expertise, use of alternatives other than antibiotics, side effects associated with the antibiotics is the challenges which can tamper the market growth.

This psittacosis treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Psittacosis Treatment Market Scope and Market Size

The psittacosis treatment market is segmented on the basis of type, antibiotic type, treatment type, route of administration, mode of purchase and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the psittacosis treatment market is segmented into chlamydia psittaci, chickens, turkeys, pigeons and parakeets.
• On the basis of antibiotic type, the psittacosis treatment market is segmented into tetracycline, chloramphenicol and doxycycline.
• On the basis of treatment type, the psittacosis treatment market is segmented into medication, antibiotic therapy and supportive care.
• On the basis of route of administration, the psittacosis treatment market is segmented into oral, parenteral, intravenous.
• On the basis of mode of purchase, the psittacosis treatment market is segmented into prescription and over the counter.
• On the basis of distribution channel, the psittacosis treatment market has also been segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.

Psittacosis Treatment Market Country Level Analysis

Psittacosis Treatment market is analysed and market size information is provided by country, type, antibiotic type, treatment type, route of administration, mode of purchase and distribution channel as referenced above.

The countries covered in the Psittacosis Treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America is expected to hold the largest market share due to the increased cases of parrot infection, increased awareness about the symptoms and prevention of Psittacosis, presence of health policies and affordability of antibiotics. Asia Pacific is also expected to account for the second largest market share due to the rise in point of care diagnostics, increased count of healthcare clinics and veterinary (bird) centers, use of vaccines and untapped opportunities in emerging markets.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Psittacosis Treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Psittacosis Treatment Market Share Analysis

Psittacosis 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 Psittacosis 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

Psittacosis 치료 시장에서 다루는 주요 기업으로는 Sanofi, Abbott, Walter Bushnell, ARISTO, Pfizer Inc., JAGSONPAL Pharmaceuticals, Dr. Reddy's Laboratories Ltd, USV Private Limited, Wyeth Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Forest Pharmaceuticals, Inc., BIOCRYST PHARMACEUTICALS, INC. 등이 있으며, 국내 및 글로벌 기업도 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60447